How Does the FDA Ensure Drug Safety in Pediatrics?
The FDA's Office of Pediatric Therapeutics (OPT) is dedicated to ensuring that pediatric populations are considered in the drug development process. This involves reviewing pediatric clinical trial data, monitoring adverse events, and updating drug labeling to include pediatric-specific information. The FDA also collaborates with other organizations to enhance pediatric drug safety and efficacy.
